The global insulin export market in dosage forms shows Germany as the leading exporter with a significant value in 2023, followed by France and Italy. Emerging markets like China and India also indicate growing contributions. Year-on-year, notable growth is observed in Greece, Slovakia, and the UAE, with Greece at a remarkable 14.43% increase, while countries like Japan and Canada experienced declines. Trend over five years shows significant activity, particularly with dynamic shifts in smaller markets such as Estonia and El Salvador.
Future trends to monitor include growth in emerging markets like China and India. Additionally, economic policies, healthcare demands, and innovation in insulin forms will influence international export dynamics. Watch for technology advancements and regulatory changes impacting production and distribution efficiency globally.
Top countries in Export of Insulin in Dosage Forms by Country
| # | 10 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 3,582,300,000 | 2023 | +0.51% | +2.22% | View data |
| 2 | 2 France | 2,309,000,000 | 2023 | +2.23% | +1.03% | View data |
| 3 | 3 Italy | 949,620,000 | 2023 | +4.72% | +4.84% | View data |
| 4 | 4 China | 416,010,000 | 2023 | +5.55% | +4.51% | View data |
| 5 | 5 United States | 195,430,000 | 2023 | -1.53% | +0.043% | View data |
| 6 | 6 India | 147,220,000 | 2023 | +3.09% | +3.39% | View data |
| 7 | 7 Hungary | 79,134,000 | 2023 | +2.22% | +1.6% | View data |
| 8 | 8 Belgium | 75,029,000 | 2023 | +4.46% | +4.4% | View data |
| 9 | 9 United Kingdom | 74,113,000 | 2023 | +2.84% | +3.11% | View data |
| 10 | 10 Czech Republic | 65,946,000 | 2023 | +4.06% | +2.87% | View data |
